Eptacog Alfa Pegol (activated) Uses, Dosage, Side Effects and more
Eptacog Alfa Pegol (activated) has been used in trials studying the prevention and treatment of Haemophilia A, Haemophilia B, Congenital Bleeding Disorder, Haemophilia B With Inhibitors, and Haemophilia A With Inhibitors.
| Trade Name | Eptacog Alfa Pegol (activated) |
| Generic | Eptacog alfa pegol (activated) |
| Eptacog alfa pegol (activated) Other Names | Activated Recombinant Human Factor VII, Long Acting, Eptacog alfa pegol (activated) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
